Value of MicroRNA30a in Philadelphia Positive Leukemic Patients

Clinical trial NCT05112653 · UNKNOWN

Trial details

NCT number: NCT05112653
Sponsor: Assiut University
Status: UNKNOWN
Study type: OBSERVATIONAL

Possibility of Using microRNA30a as a Prognostic Marker in Philadelphia Positive Leukemic Patients by Measure Level of microRNA30a in Blood Sample

Start date: 2022-04-01
Primary completion: 2024-06-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.